TORONTO, December 17 /PRNewswire/ --

- Free add-your-profile opportunity for colleges and universities on Facebook(R) Platform

Recent national surveys have found that 75% of college and university applicants are active Facebook users, and many discuss their plans for higher education using the social utility. SkoolPool(TM), a new application on Facebook Platform, offers a fast and effective way for institutions to share information with this key audience. With a SkoolPool membership, institutions get a profile page accessible through SkoolPool.com, SkoolPool on Facebook Platform, and on a Facebook Page designed and maintained by the Academica Group team.

DEERFIELD, Illinois, December 17 /PRNewswire/ --

- Third-Generation TRAb Assay Delivers Unprecedented Specificity for Diagnosing Graves' Disease

Siemens Medical Solutions Diagnostics (www.siemens.com/diagnostics) announced that it has signed an agreement with KreLo GmbH Medical Diagnostics for the rights to develop an automated stimulating TSH receptor antibody (TRAb) assay used in the differential diagnosis of Graves' disease. This agreement will make Siemens Medical Solutions Diagnostics the first in vitro diagnostics distributor of an automated TRAb assay featuring stimulating TRAb KreLo antibodies which are specific to the diagnosis of Graves' disease.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO )

STOCKHOLM, December 17 /PRNewswire/ -- Global appliance giant Electrolux has named Stockholm and New York-based Perfect Fools as its creative web production company of record. The initial one-year agreement spans all Electrolux markets in Europe and covers the group's full range of brands including Electrolux, AEG-Electrolux and Zanussi-Electrolux.

AMSTERDAM, Netherlands, December 17 /PRNewswire/ --

- Agendia to file for expanded FDA clearance for MammaPrint(R)

Agendia BV, world leader in the rapidly evolving field of molecular diagnostics, announced today that its MammaPrint(R) breast cancer prognosis test was shown to be a valuable tool to assess risk of breast cancer recurrence also in postmenopausal breast cancer patients. Data recently presented at the AACR/NCI/ EORTC conference "Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications" in San Francisco showed that MammaPrint is a valuable tool to assess risk of breast cancer recurrence in older age breast cancer patients as well.

SANTA CLARA, California, December 17 /PRNewswire/ --

Finesse Solutions, LLC, a manufacturer of measurement and control solutions for life sciences process applications, announced the general release of its TruViu(TM) RDPD system for biotech R&D and Process Development (PD) applications. The system consists of an I/O tower and a pump tower, with an optional junction box and TruFlow(TM) gas manifold, namely, all the components required to control a typical R&D or PD bioreactor.